Kindly note that this image has only been posted for representational purposes. Photograph: Ajeng Dinar Ulfiana/Reuters Following the death of 22 children due to consumption of contaminated......
'India is clearly moving toward more targeted treatment pathways in high-burden cancers.' Kindly note that this image has been posted only for representational purposes. Photograph: ANI Photo......
The Central Drugs Standard Control Organisation (CDSCO) will conduct testing, inspection and auditing of cough syrup manufacturers. IMAGE: Kindly note that this image has been posted for......
Central drug regulator Central Drugs Standard Control Organisation (CDSCO) has started a pan India drive to test, inspect and audit cough syrup manufacturers, official sources said on Thursday.......
The World Health Organisation has issued an alert against three "substandard" oral cough syrups identified in India -- Coldrif, Respifresh TR and ReLife -- and urged national regulatory authorities......
Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as the biopharmaceutical firm positions itself as a global player in the......
The bumper rise is due to the rising demand for the drug and patients' gradual shift towards its higher dosage. Photograph: Kind courtesy Raimond Spekking/CC BY-SA 4.0/wikipedia.org/Creative......
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly. Kindly note the image has been posted only for representational purposes.......
A large number of medical device-manufacturing units have been forced to move to Vietnam and Malaysia due to delays, inconsistent timelines, and a lack of transparency in licensing processes,......
According to the Department of Pharmaceuticals' annual report for 2024-25, India imported medical devices worth $8.1 billion, while exports stood at $3.7 billion in the financial year 2023-24......